Literature DB >> 7410098

Elective neck irradiation in squamous-cell carcinoma of the head and neck.

W M Mendenhall, R R Million, N J Cassisi.   

Abstract

One hundred fifty-nine patients with squamous-cell carcinoma of the oral cavity, oropharynx, nasopharynx, hypopharynx, and supraglottic larynx, and with clinically negative neck (Stage NO) were reviewed to determine the value of elective neck irradiation (ENI). The primary cancer was controlled in 125 patients; in these patients the neck failure rate was 1.9% with ENI and 18% without ENI. Recurrence in the neck in cases where the primary cancer was controlled was associated with an increased risk of death due to cancer. The primary cancer was not controlled in 34 patients; in these patients the neck failure rate was 25% with ENI and 67% without ENI. Ten of 11 patients in whom treatment failed both at the primary site and in the neck died of cancer despite attempts at surgical salvage. ENI may be associated with an increased risk of local failure in oral tongue lesions as a result of a decreased proportion of treatment given with interstitial therapy.

Entities:  

Mesh:

Year:  1980        PMID: 7410098     DOI: 10.1002/hed.2890030105

Source DB:  PubMed          Journal:  Head Neck Surg        ISSN: 0148-6403


  11 in total

Review 1.  Management of cervical lymph nodes in patients with head and neck cancer.

Authors:  G B Snow; P Patel; C R Leemans; R Tiwari
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

2.  Lymph node yield and lymph node density for elective level II-IV neck dissections in laryngeal squamous cell carcinoma patients.

Authors:  Melih Cayonu; Evrim Unsal Tuna; Aydın Acar; Ayse Secil Kayalı Dinc; Muammer Melih Sahin; Suleyman Boynuegri; Adil Eryilmaz
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-17       Impact factor: 2.503

3.  [The locoregional recurrence of rectal carcinoma. A computed tomographic analysis and a target volume concept for adjuvant radiotherapy].

Authors:  A Bagatzounis; O Kölbl; G Müller; U Oppitz; J Willner; M Flentje
Journal:  Strahlenther Onkol       Date:  1997-02       Impact factor: 3.621

Review 4.  Target Definition in MR-Guided Adaptive Radiotherapy for Head and Neck Cancer.

Authors:  Mischa de Ridder; Cornelis P J Raaijmakers; Frank A Pameijer; Remco de Bree; Floris C J Reinders; Patricia A H Doornaert; Chris H J Terhaard; Marielle E P Philippens
Journal:  Cancers (Basel)       Date:  2022-06-20       Impact factor: 6.575

5.  Intraoperative radiation therapy for advanced cervical metastasis: a single institution experience.

Authors:  Youssef H Zeidan; Alex Yeh; Daniel Weed; Colin Terry; Stephen Freeman; Edward Krowiak; Robert Borrowdale; Tod Huntley
Journal:  Radiat Oncol       Date:  2011-06-15       Impact factor: 3.481

6.  Regional recurrence of oropharyngeal cancer after definitive radiotherapy: a case control study.

Authors:  Karin Söderström; Per Nilsson; Tina Dalianis; Elisabeth Kjellén; Björn Zackrisson
Journal:  Radiat Oncol       Date:  2015-05-27       Impact factor: 3.481

Review 7.  Review of surgical resection and reconstruction in head and neck cancer. Traditional versus current concepts.

Authors:  Afnan F Alfouzan
Journal:  Saudi Med J       Date:  2018-10       Impact factor: 1.484

8.  Incidence of contralateral regional failure in the electively irradiated contralateral neck of patients with head and neck squamous cell carcinoma.

Authors:  Pieter D de Veij Mestdagh; Eric van Werkhoven; Arash Navran; Jan Paul de Boer; Willem H Schreuder; Wouter V Vogel; Abrahim Al-Mamgani
Journal:  Clin Transl Radiat Oncol       Date:  2019-04-19

9.  A quantitative comparison of gross tumour volumes delineated on [18F]-FDG PET-CT scan and CECT scan in head and neck cancers.

Authors:  Manickam G Venkada; Sheh Rawat; Ps Choudhury; T Rajesh; Sa Rao; Pooja Khullar; Anjali Kakria
Journal:  Indian J Nucl Med       Date:  2012-04

10.  Elective Neck Dissection for Management of Early- Stage Oral Tongue Cancer

Authors:  Zeiad S Gad; Osama A El-Malt; Mostafa A T El-Sakkary; Mohamed M Abdal Aziz
Journal:  Asian Pac J Cancer Prev       Date:  2018-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.